Immunology in the clinic review series; focus on type 1 diabetes and viruses: The innate immune response to enteroviruses and its possible role in regulating type 1 diabetes

Clinical and Experimental Immunology

Volumn 168, Issue 1, 2012, Pages 30-38

  Lind, K ^a   Huhn M H ^b   Flodstrom Tullberg M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Enterovirus; Innate immunity; Interferon; RIG I like receptors; Type 1 diabetes

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 2R1; INTERFERON; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; UNCLASSIFIED DRUG; VITAMIN D;

ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; CELLULAR DISTRIBUTION; CYTOTOXICITY; ENTEROVIRUS; ENTEROVIRUS INFECTION; GENE LOCUS; HEREDITY; HUMAN; IFIH1 GENE; IMMUNE RESPONSE; IMMUNOREGULATION; INFECTION RISK; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MDA5 GENE; MICROORGANISM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; VIRUS GENE; VITAMIN METABOLISM;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IMMUNITY, INNATE; INSULIN-SECRETING CELLS; RECEPTORS, PATTERN RECOGNITION; T-LYMPHOCYTES;

EID: 84857737745     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04557.x     Document Type: Review

References (77)

1. Coppieters KT, Wiberg A, Tracy SM, von Herrath MG. Immunology in the clinic review series; focus on type 1 diabetes and viruses: the role of viruses in type 1 diabetes: a difficult dilemma. Clin Exp Immunol 2012; 168:5-11.
2. Stene LC, Rewers M. Immunology in the clinic review series; focus on type 1 diabetes and viruses: the enterovirus link to type 1 diabetes: critical review of human studies. Clin Exp Immunol 2012; 168:12-23.
3. Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol 2011; 30:16-34.
4. Stetson DB, Medzhitov R. Antiviral defense: interferons and beyond. J Exp Med 2006; 203:1837-41.
5. Blasius AL, Beutler B. Intracellular toll-like receptors. Immunity 2010; 32:305-15.
6. Jeong E, Lee JY. Intrinsic and extrinsic regulation of innate immune receptors. Yonsei Med J 2011; 52:379-92.
7. Zhang Z, Kim T, Bao M etal. DDX1, DDX21, and DHX36 helicases form a complex with the adaptor molecule TRIF to sense dsRNA in dendritic cells. Immunity 2011; 34:866-78.
8. Grieco F, Sebastiani G, Spagnuolo I, Patti A, Dotta F. Immunology in the clinic review series; focus on type 1 diabetes and viruses: how viral infections modulate beta cell function. Clin Exp Immunol 2012; 168:24-9.
9. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011; 34:637-50.
10. Swiecki M, McCartney SA, Wang Y, Colonna M. TLR7/9 versus TLR3/MDA5 signaling during virus infections and diabetes. J Leukoc Biol 2011; 90:691-701.
11. Hultcrantz M, Hühn M, Wolf HM etal. Interferons induce an antiviral state in human pancreatic islets. Virology 2007; 367:92-101.
12. Stene LC, Oikarinen S, Hyoty H etal. Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY). Diabetes 2010; 59:3174-80.
13. Roivainen M, Klingel K. Virus infections and type 1 diabetes risk. Curr Diab Rep 2010; 10:350-6.
14. Tauriainen S, Oikarinen S, Oikarinen M, Hyoty H. Enteroviruses in the pathogenesis of type 1 diabetes. Semin Immunopathol 2011; 33:45-55.
15. Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ (Clin Res Ed) 2011; 342:d35.
16. Deonarain R, Cerullo D, Fuse K, Liu PP, Fish EN. Protective role for interferon-beta in coxsackievirus B3 infection. Circulation 2004; 110:3540-3.
17. Flodstrom M, Maday A, Balakrishna D, Cleary MM, Yoshimura A, Sarvetnick N. Target cell defense prevents the development of diabetes after viral infection. Nat Immunol 2002; 3:373-82.
18. Wessely R, Klingel K, Knowlton KU, Kandolf R. Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication. Circulation 2001; 103:756-61.
19. Flodstrom M, Horwitz MS, Maday A, Balakrishna D, Rodriguez E, Sarvetnick N. A critical role for inducible nitric oxide synthase in host survival following coxsackievirus B4 infection. Virology 2001; 281:205-15.
20. Flodstrom-Tullberg M, Hultcrantz M, Stotland A etal. RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection. J Immunol 2005; 174:1171-7.
21. Zaragoza C, Ocampo CJ, Saura M etal. Inducible nitric oxide synthase protection against coxsackievirus pancreatitis. J Immunol 1999; 163:5497-504.
22. Flodstrom M, Tsai D, Fine C, Maday A, Sarvetnick N. Diabetogenic potential of human pathogens uncovered in experimentally permissive beta-cells. Diabetes 2003; 52:2025-34.
23. Triantafilou K, Orthopoulos G, Vakakis E etal. Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll-like receptor (TLR) 8-dependent. Cell Microbiol 2005; 7:1117-26.
24. Triantafilou K, Triantafilou M. Coxsackievirus B4-induced cytokine production in pancreatic cells is mediated through toll-like receptor 4. J Virol 2004; 78:11313-20.
25. Wang JP, Asher DR, Chan M, Kurt-Jones EA, Finberg RW. Cutting edge: antibody-mediated TLR7-dependent recognition of viral RNA. J Immunol 2007; 178:3363-7.
26. Fuse K, Chan G, Liu Y etal. Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production. Circulation 2005; 112:2276-85.
27. Fairweather D, Yusung S, Frisancho S etal. IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta- and IL-18-associated myocarditis and coxsackievirus replication. J Immunol 2003; 170:4731-7.
28. Huhn MH, McCartney SA, Lind K, Svedin E, Colonna M, Flodstrom-Tullberg M. Melanoma differentiation-associated protein-5 (MDA-5) limits early viral replication but is not essential for the induction of type 1 interferons after Coxsackievirus infection. Virology 2010; 401:42-8.
29. Negishi H, Osawa T, Ogami K etal. A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proc Natl Acad Sci USA 2008; 105:20446-51.
30. Richer MJ, Horwitz MS. Coxsackievirus infection as an environmental factor in the etiology of type 1 diabetes. Autoimmun Rev 2009; 8:611-15.
31. Wang JP, Cerny A, Asher DR, Kurt-Jones EA, Bronson RT, Finberg RW. MDA5 and MAVS mediate type I interferon responses to coxsackie B virus. J Virol 2010; 84:254-60.
32. Riad A, Westermann D, Zietsch C etal. TRIF is a critical survival factor in viral cardiomyopathy. J Immunol 2011; 186:2561-70.
33. Stene LC, Rewers M. The enterovirus link to type 1 diabetes: critical review of human studies. Clin Exp Immunol 2012; 168:12-23.
34. Richardson SJ, Willcox A, Bone AJ, Morgan NG, Foulis AK. Immunopathology of the human pancreas in type-I diabetes. Semin Immunopathol 2011; 33:9-21.
35. Rowe PA, Campbell-Thompson ML, Schatz DA, Atkinson MA. The pancreas in human type 1 diabetes. Semin Immunopathol 2011; 33:29-43.
36. Flodstrom-Tullberg M. Viral infections: their elusive role in regulating susceptibility to autoimmune disease. Microbes Infect 2003; 5:911-21.
37. Munz C, Lunemann JD, Getts MT, Miller SD. Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol 2009; 9:246-58.
38. Dotta F, Censini S, van Halteren AG etal. Coxsackie B4 virus infection of beta-cells and NK cell insulitis in recent onset type 1 diabetic patients. Proc Natl Acad Sci USA 2007; 104:5115-20.
39. Oikarinen M, Tauriainen S, Honkanen T etal. Analysis of pancreas tissue in a child positive for islet cell antibodies. Diabetologia 2008; 51:1796-802.
40. Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 2009; 52:1143-51.
41. Ylipaasto P, Klingel K, Lindberg AM etal. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 2004; 47:225-39.
42. Roivainen M, Rasilainen S, Ylipaasto P etal. Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells. J Clin Endocrinol Metab 2000; 85:432-40.
43. Roivainen M, Ylipaasto P, Savolainen C, Galama J, Hovi T, Otonkoski T. Functional impairment and killing of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains. Diabetologia 2002; 45:693-702.
44. Szopa TM, Gamble DR, Taylor KW. Coxsackie B4 virus induces short-term changes in the metabolic functions of mouse pancreatic islets in vitro. Cell Biochem Funct 1986; 4:181-7.
45. Yoon JW, Austin M, Onodera T, Notkins AL. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979; 300:1173-9.
46. Bowles NE, Bayston TA, Zhang HY etal. Persistence of enterovirus RNA in muscle biopsy samples suggests that some cases of chronic fatigue syndrome result from a previous, inflammatory viral myopathy. J Med 1993; 24:145-60.
47. Kim KS, Tracy S, Tapprich W etal. 5′-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA. J Virol 2005; 79:7024-41.
48. Zanone MM, Favaro E, Conaldi PG etal. Persistent infection of human microvascular endothelial cells by coxsackie B viruses induces increased expression of adhesion molecules. J Immunol 2003; 171:438-46.
49. Tsunoda I, Fujinami RS. Neuropathogenesis of Theiler's murine encephalomyelitis virus infection, an animal model for multiple sclerosis. J Neuroimmune Pharmacol 2010; 5:355-69.
50. Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry [see comments]. Nat Med 1998; 4:781-5.
51. Ida-Hosonuma M, Iwasaki T, Yoshikawa T etal. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J Virol 2005; 79:4460-9.
52. Oikarinen M, Tauriainen S, Honkanen T etal. Detection of enteroviruses in the intestine of type 1 diabetic patients. Clin Exp Immunol 2008; 151:71-5.
53. Crow MK. Interferon-alpha: a therapeutic target in systemic lupus erythematosus. Rheum Dis Clin North Am 2010; 36:173-86.
54. Smyth DJ, Cooper JD, Bailey R etal. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 2006; 38:617-9.
55. Nejentsev S, Walker N, Riches D, Egholm M, Todd JA. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 2009; 324:387-9.
56. Chistiakov DA, Voronova NV, Savost'Anov KV, Turakulov RI. Loss-of-function mutations E6 27X and I923V of IFIH1 are associated with lower poly(I:C)-induced interferon-beta production in peripheral blood mononuclear cells of type 1 diabetes patients. Hum Immunol 2010; 71:1128-34.
57. Liu S, Wang H, Jin Y etal. IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells. Hum Mol Genet 2009; 18:358-65.
58. Strange A, Capon F, Spencer CC etal. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 2010; 42:985-90.
59. Sutherland A, Davies J, Owen CJ etal. Genomic polymorphism at the interferon-induced helicase (Ifih1) locus contributes to Graves' disease susceptibility. J Clin Endocrinol Metab 2007; 92:3338-41.
60. Gateva V, Sandling JK, Hom G etal. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 2009; 41:1228-33.
61. Harley JB, Alarcon-Riquelme ME, Criswell LA etal. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008; 40:204-10.
62. Shigemoto T, Kageyama M, Hirai R, Zheng J, Yoneyama M, Fujita T. Identification of loss of function mutations in human genes encoding RIG-I and MDA5: implications for resistance to type I diabetes. J Biol Chem 2009; 284:13348-54.
63. Downes K, Pekalski M, Angus KL etal. Reduced expression of IFIH1 is protective for type 1 diabetes. PLoS ONE 2010; 5:pii:e12646.
64. Zouk H, Marchand L, Polychronakos C. Study of transcriptional effects in Cis at the IFIH1 locus. PLoS ONE 2010; 5:e11564.
65. Robinson T, Kariuki SN, Franek BS etal. Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-alpha and serologic autoimmunity in lupus patients. J Immunol 2011; 187:1298-303.
66. Mukherjee A, Morosky SA, Delorme-Axford E etal. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog 2011; 7:e1001311.
67. Beard JA, Bearden A, Striker R. Vitamin D and the anti-viral state. J Clin Virol 2011; 50:194-200.
68. Wolden-Kirk H, Overbergh L, Christesen HT, Brusgaard K, Mathieu C. Vitamin D and diabetes: its importance for beta cell and immune function. Mol Cell Endocrinol 2011; 347:106-20.
69. Wang TJ, Zhang F, Richards JB etal. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010; 376:180-8.
70. Ramagopalan SV, Heger A, Berlanga AJ etal. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res 2010; 20:1352-60.
71. Bailey R, Cooper JD, Zeitels L etal. Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 2007; 56:2616-21.
72. Cooper JD, Smyth DJ, Walker NM etal. Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes 2011; 60:1624-31.
73. Lopez ER, Regulla K, Pani MA, Krause M, Usadel KH, Badenhoop K. CYP27B1 polymorphisms variants are associated with type 1 diabetes mellitus in Germans. J Steroid Biochem Mol Biol 2004; 89-90:155-7.
74. Blanton D, Han Z, Bierschenk L etal. Reduced serum vitamin D-binding protein levels are associated with type 1 diabetes. Diabetes 2011; 60:2566-70.
75. Gal-Tanamy M, Bachmetov L, Ravid A etal. Vitamin-D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes. Hepatology 2011; 54:1570-9.
76. Cooper JD, Walker NM, Smyth DJ, Downes K, Healy BC, Todd JA. Follow-up of 1715 SNPs from the Wellcome Trust Case Control Consortium genome-wide association study in type I diabetes families. Genes Immun 2009; 10 (Suppl. 1):S85-94.
77. Heinig M, Petretto E, Wallace C etal. A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk. Nature 2011; 467:460-4.